LATEST MANUSCRIPTS IN Cancer Research Communications
Jitendra Badhai, Nick Landman, Gaurav Kumar Pandey, Ji-Ying Song, Danielle Hulsman, Oscar Krijgsman, Gayathri Chandrasekaran, Anton Berns, Maarten van Lohuizen. Combined Inhibition of EZH2 and FGFR is Synergistic in BAP1-deficient Malignant Mesothelioma.Cancer research communications. 2024, 4 (1): 18-27
Josep Tabernero, Takayuki Yoshino, Sebastian Stintzing, Aimery de Gramont, Peter Gibbs, Derek J Jonker, Peter Nygren, Christos Papadimitriou, Gerald W Prager, Roger Tell, Heinz-Josef Lenz. A Randomized Phase III Study of Arfolitixorin versus Leucovorin with 5-Fluorouracil, Oxaliplatin, and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer: The AGENT Trial.Cancer research communications. 2024, 4 (1): 28-37
Poornima Bhat-Nakshatri, Aditi S Khatpe, Duojiao Chen, Katie Batic, Henry Mang, Christopher Herodotou, Patrick C McGuire, Xiaoling Xuei, Cihat Erdogan, Hongyu Gao, Yunlong Liu, George Sandusky, Anna Maria Storniolo, Harikrishna Nakshatri. Signaling Pathway Alterations Driven by BRCA1 and BRCA2 Germline Mutations are Sufficient to Initiate Breast Tumorigenesis by the PIK3CAH1047R Oncogene.Cancer research communications. 2024, 4 (1): 38-54
Maira Soto, Erin L Filbert, Hai Yang, Stephanie Starzinski, Alec Starzinski, Marissa Gin, Brandon K Chen, Phi Le, Tony Li, Brandon Bol, Alexander Cheung, Li Zhang, Frank J Hsu, Andrew H Ko, Lawrence Fong, Bridget P Keenan. Neoadjuvant CD40 agonism remodels the tumor immune microenvironment in locally advanced esophageal/gastroesophageal junction cancer.Cancer research communications. 2024, :
Emily M Rencsok, Natalie Slopen, Hannah D McManus, Karen A Autio, Alicia K Morgans, Lawrence McSwain, Pedro Barata, Heather H Cheng, Robert Dreicer, Travis Gerke, Rebecca Green, Elisabeth I Heath, Lauren E Howard, Rana R McKay, Joel Nowak, Shannon Pileggi, Mark M Pomerantz, Dana E Rathkopf, Scott T Tagawa, Young E Whang, Camille Ragin, Folakemi T Odedina, Philip W Kantoff, Jake Vinson, Paul Villanti, Sebastien Haneuse, Lorelei A Mucci, Daniel J George. Pain and its association with survival for Black and White individuals with advanced prostate cancer in the US.Cancer research communications. 2023, 4 (1): 55-64
Dalia Haydar, Jorge Ibañez-Vega, Jeremy Chase Crawford, Ching-Heng Chou, Clifford S Guy, Michaela Meehl, Zhongzhen Yi, Scott Perry, Jonathan Laxton, Trevor Cunningham, Deanna Langfitt, Peter Vogel, Christopher DeRenzo, Stephen Gottschalk, Martine F Roussel, Paul G Thomas, Giedre Krenciute. CAR T-cell Design-dependent Remodeling of the Brain Tumor Immune Microenvironment Modulates Tumor-associated Macrophages and Anti-glioma Activity.Cancer research communications. 2023, 3 (12): 2430-2446
Paul B Chapman, Mark Klang, Michael A Postow, Alexander Noor Shoushtari, Ryan J Sullivan, Jedd D Wolchok, Taha Merghoub, Sadna Budhu, Phillip Wong, Margaret K Callahan, Bin Zheng, Jonathan Zippin. Phase Ib Trial of Phenformin in Patients with V600-mutated Melanoma Receiving Dabrafenib and Trametinib.Cancer research communications. 2023, 3 (12): 2447-2454
Andrea R Daniel, Chang Su, Nerissa T Williams, Zhiguo Li, Jianguo Huang, Omar Lopez, Lixia Luo, Yan Ma, Lorraine da Silva Campos, Sara R Selitsky, Jennifer L Modliszewski, Siyao Liu, Rosa Hernansaiz-Ballesteros, Yvonne M Mowery, Diana M Cardona, Chang-Lung Lee, David G Kirsch. Temporary Knockdown of p53 During Focal Limb Irradiation Increases the Development of Sarcomas.Cancer research communications. 2023, 3 (12): 2455-2467
Shadin Ahmed, Mary Frances Wedekind, Jaydira Del Rivero, Margarita Raygada, Robin Lockridge, John W Glod, Crystal Flowers, B J Thomas, Donna B Bernstein, Oxana B Kapustina, Ashish Jain, Markku Miettinen, Mark Raffeld, Liqiang Xi, Manoj Tyagi, Jung Kim, Kenneth Aldape, Ashkan A Malayeri, Rosandra N Kaplan, Taryn Allen, Christina A Vivelo, Abby B Sandler, Brigitte C Widemann, Karlyne M Reilly, . Longitudinal Natural History Study of Children and Adults with Rare Solid Tumors: Initial Results for First 200 Participants.Cancer research communications. 2023, 3 (12): 2468-2482
William Echavidre, Jérôme Durivault, Célia Gotorbe, Thays Blanchard, Marina Pagnuzzi, Valérie Vial, Florian Raes, Alexis Broisat, Rémy Villeneuve, Régis Amblard, Nicolas Garnier, Cécile Ortholan, Marc Faraggi, Benjamin Serrano, Vincent Picco, Christopher Montemagno. Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and Radioresistance.Cancer research communications. 2023, 3 (12): 2483-2496
Dennis Juarez, Roberta Buono, Shannon M Matulis, Vikas A Gupta, Madeleine Duong, Jacob Yudiono, Madhuri Paul, Sharmila Mallya, Grace Diep, Peter Hsin, Alexander Lu, Sang Mi Suh, Vy M Dong, Andrew W Roberts, Joel D Leverson, Muhammad Jalaluddin, Zhuangzhuang Liu, Orlando F Bueno, Lawrence H Boise, David A Fruman. Statin-induced Mitochondrial Priming Sensitizes Multiple Myeloma Cells to BCL2 and MCL-1 Inhibitors.Cancer research communications. 2023, 3 (12): 2497-2509
Kristen Simmons, Jane V Thomas, Kaysia Ludford, Jason A Willis, Victoria S Higbie, Kanwal P S Raghav, Benny Johnson, Arvind Dasari, Bryan K Kee, Christine M Parseghian, Michael S Lee, Phat H Le, Maria P Morelli, John Paul Shen, Alisha Bent, Eduardo Vilar, Robert A Wolff, Scott Kopetz, Michael J Overman, Van Karlyle Morris. Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment Termination.Cancer research communications. 2023, 3 (12): 2510-2517